✓
Open
26 Aug 2025
✓
Close
29 Aug 2025
3
Allotment
—
✓
Listing
Wed, Sep 3, 2025
Price Band
₹86 to ₹91
Issue Size
1,33,00,000 shares (agg. up to ₹121 Cr)
Lot Size
164 Shares
Listing Date
Wed, Sep 3, 2025
Latest GMP
₹1
Est. Gain
1.1%
✦ AI Insight
GMP Trend
03-09-2025₹1Est. ₹92+1.1%
02-09-2025₹1Est. ₹92+1.1%
01-09-2025₹2Est. ₹93+2.2%
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 6.95x |
Restated Financials (₹ Cr.)
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 181.30 | 128.00 | 111.55 |
| Total Income | 120.46 | 66.69 | 113.12 |
| Profit After Tax | 20.52 | 9.66 | 5.82 |
| EBITDA | 32.38 | 15.57 | 12.66 |
| NET Worth | 80.42 | 21.03 | 7.37 |
| Reserves and Surplus | 40.57 | 5.03 | -4.63 |
| Total Borrowing | 58.35 | 74.56 | 66.39 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Senores Pharmaceuticals Ltd. | Mainboard | ₹582.11 Cr | ₹391 | 39.77 | ₹557.80 | +42.66% | ₹1,509.80 |
| Sai Life Sciences Ltd. | Mainboard | ₹3,042.62 Cr | ₹549 | 126.42 | ₹764.65 | +39.28% | ₹1,647.10 |
| Asston Pharmaceuticals Ltd. | SME | ₹27.56 Cr | ₹123 | 17.83 | ₹124.95 | +1.59% | ₹110.00 |
| Influx Healthtech Ltd. | SME | ₹58.57 Cr | ₹96 | 13.04 | ₹126.20 | +31.46% | ₹283.70 |
| Astonea Labs Ltd. | SME | ₹37.67 Cr | ₹135 | 27.36 | ₹135.65 | +0.48% | ₹289.00 |
| Accretion Pharmaceuticals Ltd. | SME | ₹29.75 Cr | ₹101 | 21.29 | ₹82.95 | -17.87% | ₹210.00 |
| Amwill Health Care Ltd. | SME | ₹59.98 Cr | ₹111 | 13.81 | ₹93.25 | -15.99% | ₹43.51 |
| Sat Kartar Shopping Ltd. | SME | ₹33.80 Cr | ₹81 | 14.87 | ₹161.55 | +99.44% | ₹117.00 |
| Onyx Biotec Ltd. | SME | ₹29.34 Cr | ₹61 | 26.81 | ₹56.75 | -6.97% | ₹37.55 |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Funding capital expenditure requirements for Proposed Expansion | 30.72 |
| 2 | Full or part repayment and/or prepayment of certain outstanding secured borrowingssecured borrowing (term loan)availed by the Company | 5.00 |
| 3 | Funding the working capital requirements of the Company | 43.15 |
| 4 | General Corporate Purposes | 27.03 |
| 5 | Issue Expenses | 15.13 |
| Total | 121.03 |
About Anlon Healthcare IPO
Updated on Aug 5, 2026
Contact Details
Anlon Healthcare Ltd. Address101/102, Silvercoin ComplexOpp.Crystal MallKalawad RoadRajkot, Gujarat, 360005+91 281 2562538cs@anloncro.comVisit Website